CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
Go back to CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results| (NASDAQ: CRSP) | Delayed: 58.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.33 | 52 Week High | $18.88 | |||
| Open | $58.33 | 52 Week Low | $13.75 | |||
| Day High | $58.33 | P/E | N/A | |||
| Day Low | $58.33 | EPS | $0.00 | |||
| Volume | 4,066 | |||||

